Publikationen von Junxue Dong

Qiang, M.; Chen, Z.; Liu, H.; Dong, J.; Gong, K.; Zhang, X.; Huo, P.; Zhu, J.; Shao, Y.; Ma, J. et al.; Zhang, B.; Liu, W.; Tang, M.: Targeting the PI3K/AKT/mTOR pathway in lung cancer: mechanisms and therapeutic targeting. Frontiers in Pharmacology, 16:1516583. (2025)

Dong, J.; Holthaus, D.; Peters, C.; Koster, S.; Ehsani, M.; Quevedo-Olmos, A.; Berger, H.; Zarobkiewicz, M.; Mangler, M.; Gurumurthy, R. K. et al.; Hedemann, N.; Chumduri, C.; Kabelitz, D.; Meyer, T. F.: γδ T cell-mediated cytotoxicity against patient-derived healthy and cancer cervical organoids. Frontiers in Immunology 14, 1281646. (2023)

Tang, M.; Gao, X.; Sun, H.; Tian, S.; Dong, J.; Liu, Z.; Liu, W.: Neutrophil-Lymphocyte Ratio as a Prognostic Parameter in NSCLC Patients Receiving EGFR-TKIs: A Systematic Review and Meta-Analysis. Journal of Oncology 2021 (2021)

Wang, D.; Xu, T.; Zhu, H.; Dong, J.; Fu, L.: Primary malignant melanomas of the female lower genital tract: clinicopathological characteristics and management. American Journal of Cancer Research 10 (12), S. 4017 - 4037 (2020)

Wang, D.; He, J.; Dong, J.; Meyer, T. F.; Xu, T.: The HIPPO pathway in gynecological malignancies. American journal of cancer research 10 (2), S. 610 - 629 (2020)